Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
Amy Jamieson, Tjalling Bosse, Jessica N. McAlpine
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Endometrial cancer
Emma J. Crosbie, Sarah Kitson, Jessica N. McAlpine, et al.
The Lancet (2022) Vol. 399, Iss. 10333, pp. 1412-1428
Open Access | Times Cited: 759
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
Alicia León‐Castillo, Nanda Horeweg, Elke E.M. Peters, et al.
Gynecologic Oncology (2022) Vol. 164, Iss. 3, pp. 577-586
Open Access | Times Cited: 76
Current and Emerging Prognostic Biomarkers in Endometrial Cancer
Kelechi Njoku, Chloe E. Barr, Emma J. Crosbie
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Advances in Stigmasterol on its anti-tumor effect and mechanism of action
Xiaoyu Zhang, Jiayun Wang, Lin Zhu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 48
Current Approaches to the Management of Patients with Endometrial Cancer
Emmanouil Kalampokas, Georgios Giannis, Theodoros Kalampokas, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4500-4500
Open Access | Times Cited: 44
Endometrial cancer: Part I. Basic concept
Peng‐Hui Wang, Szu‐Ting Yang, Chia-Hao Liu, et al.
Taiwanese Journal of Obstetrics and Gynecology (2022) Vol. 61, Iss. 6, pp. 951-959
Closed Access | Times Cited: 42
Endometrial Cancer: Transitioning from Histology to Genomics
Cristina Mitric, Marcus Q. Bernardini
Current Oncology (2022) Vol. 29, Iss. 2, pp. 741-757
Open Access | Times Cited: 40
Biomarker-driven therapy in endometrial cancer
Hannah Karpel, Brian M. Slomovitz, Robert L. Coleman, et al.
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 343-350
Open Access | Times Cited: 26
Antibody-Drug Conjugates in Gynecologic Cancer
Hannah Karpel, Sachia Stonefeld Powell, Bhavana Pothuri
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 24
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection
Natalia Galant, Paweł Krawczyk, Marta Monist, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5893-5893
Open Access | Times Cited: 15
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer
Ilaria Betella, Caterina Fumagalli, Paola Rafaniello Raviele, et al.
International Journal of Gynecological Cancer (2022) Vol. 32, Iss. 8, pp. 993-1000
Closed Access | Times Cited: 38
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
Cathalijne Post, Anneke M. Westermann, Ingrid Boere, et al.
Gynecologic Oncology (2022) Vol. 165, Iss. 2, pp. 223-229
Open Access | Times Cited: 32
Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer
Sylvie Streel, Alixe Salmon, Adriane Dheur, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4866-4866
Open Access | Times Cited: 19
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
Dario de Biase, Thais Maloberti, Angelo Gianluca Corradini, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.
Martina Arcieri, Giuseppe Vizzielli, Tommaso Occhiali, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 7, pp. 108436-108436
Open Access | Times Cited: 7
Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies
Mohamed Amine Bani, Amandine Maulard, Philippe Morice, et al.
Anticancer Research (2024) Vol. 44, Iss. 2, pp. 445-452
Open Access | Times Cited: 6
Molecular testing for endometrial cancer: An SGO clinical practice statement
Christine Walsh, Kari Hacker, Angeles Alvarez Secord, et al.
Gynecologic Oncology (2022) Vol. 168, pp. 48-55
Closed Access | Times Cited: 26
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion
Amy Jamieson, Marcel Grube, Samuel Leung, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 4, pp. 544-549
Open Access | Times Cited: 6
Lower limb lymphedema after surgical staging for endometrial cancer: Current insights and future directions
Giuseppe Cucinella, Mariano Catello Di Donna, Jvan Casarin, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 4, pp. 500-505
Open Access | Times Cited: 5
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
Emily F. Thompson, Jutta Huvila, Amy Jamieson, et al.
Modern Pathology (2022) Vol. 35, Iss. 12, pp. 1974-1982
Open Access | Times Cited: 20
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape
Amy Jamieson, Lisa Barroilhet, Jessica N. McAlpine
Cancer (2022) Vol. 128, Iss. 15, pp. 2853-2857
Closed Access | Times Cited: 19
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Nirmala Chandralega Kampan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15233-15233
Open Access | Times Cited: 12
Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review
Melinda-Ildiko Mitranovici, Diana Maria Chiorean, Liviu Moraru, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 311-311
Open Access | Times Cited: 4
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs
Angela Santoro, Emma Bragantini, Francesca Castiglione, et al.
Pathologica (2024) Vol. 116, Iss. 1, pp. 32-45
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top